Income Taxes - Schedule of Effective Tax Rates (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income tax benefit at combined statutory rates, Amount	$ 296	$ 1,105	$ 2,772	$ 3,074
Change of valuation allowance, Amount	(5,426)	(3,007)	(10,435)	(9,978)
(Shortfall) excess tax benefits related to share-based compensation, Amount	(23)	(28)	(152)	713
Changes to tax reserves, Amount	(251)	892	(411)	1,449
Gain on sale of Maoyan investment not taxable, Amount				(1,367)
Withholding taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries, Amount				(547)
Changes to deferred tax assets and liabilities resulting from audit and other tax return adjustments, Amount	2,497	(700)	2,497	(700)
Other non-deductible/non-taxable items, Amount	(226)	(208)	(14)	(392)
Income tax expense	$ (3,133)	$ (1,946)	$ (5,743)	$ (5,014)
Income tax (expense) benefit at combined statutory rates, Rate	26.50%	26.50%	26.50%	26.50%
Change of valuation allowance, Rate	(485.30%)	(72.20%)	(99.80%)	(86.00%)
(Shortfall) excess tax benefits related to share-based compensation. Rate	(2.10%)	(0.70%)	(1.50%)	6.10%
Changes to tax reserves, Rate	(22.50%)	21.40%	(3.90%)	12.50%
Gain on sale of Maoyan investment not taxable, Rate				11.80%
Withholding taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries, Rate				(4.70%)
Changes to deferred tax assets and liabilities resulting from audit and other tax return adjustments, Rate	223.40%	(16.80%)	23.90%	(6.00%)
Other non-deductible/non-taxable items, Rate	(20.20%)	(5.00%)	0.10%	(3.40%)
Income tax expense	(280.20%)	(46.70%)	(54.90%)	(43.20%)